Drawing for IMPEL

USPTO serial 87279985

IMPEL

Reviewed by CopyMark Law Group

Reg. 5246085Status 702Renewal
Filing date
Status date
Registration date
Jul 18, 2017
Examiner
KAJUBI, ELIZABETH N
Law office
TMEG LAW OFFICE 107

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with IMPEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven M. Forte

Steven M. Forte Honigman LLP39400 Woodward Avenue, Suite 101Bloomfield Hills, MI 48304-5151United States

Goods and services

ClassDescriptionStatusFirst use
010Drug delivery systems; Dosing aids and apparatus for medicines, namely, drug delivery and dispensing devices and systems; Dosing aids and apparatus for medicines, in particular for medicines in liquid and granulated form, namely, machines for dispensing pre-determined dosages of medication; Nasal, respiratory, and sinus drug delivery devices and parts thereforACTIVEMay 3, 2009
042Biomedical research services; Research and development of new products for medicinal use for others; Development and testing of pharmaceutical products and drug delivery technology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical drug development; Drug development services in the fields of drug dosage and drug dosage form, drug delivery technologies, drug analytical methods, drug manufacturing, drug packaging, drug labeling, and drug stability, storage, and testingACTIVEMay 3, 2009

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 18, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Sep 25, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 9, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 9, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 9, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 3, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 8, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 8, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 8, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 8, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 28, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 8, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 8, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 8, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 9, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Jul 18, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 1, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 30, 2020COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Apr 29, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 27, 2020ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jan 29, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 21, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 21, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 18, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 2, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 2, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 12, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 23, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2017DOCKASSIGNED TO EXAMINER—
Jan 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 27, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance